# Diarrhea management: from pathophysiology to microbiota modulation

**Authors:** Giovanni Marasco, David Meacci, Giovanni Sarnelli, Cesare Tosetti, Cesare Cremon, Edoardo Vincenzo Savarino, Giovanni Barbara

PMC · DOI: 10.1177/17562848261424324 · Therapeutic Advances in Gastroenterology · 2026-02-22

## TL;DR

This review explores the causes and treatments of acute and chronic diarrhea, emphasizing the role of gut microbiota and strategies to modulate it.

## Contribution

The paper provides a comprehensive overview of diarrhea pathophysiology and highlights microbiota modulation as a therapeutic approach.

## Key findings

- Acute diarrhea is often infectious and self-limiting, while chronic diarrhea involves persistent gut microbiota changes.
- Dysbiosis is a common feature in both acute and chronic diarrhea, linking microbial imbalance to disease progression.
- Therapeutic strategies like prebiotics, probiotics, and fecal microbiota transplantation are reviewed for microbiota modulation.

## Abstract

Diarrhea, whether acute or chronic, is a common clinical condition with numerous causes that collectively impose significant health, economic, social, and psychological burdens worldwide. Based on its duration, diarrhea is classified as acute when lasting less than 2 weeks and chronic when persisting for more than 4 weeks. From a pathophysiological standpoint, diarrhea can be categorized into four main types: osmotic, secretory, inflammatory, and motility-related. Acute diarrhea is most commonly caused by infectious gastroenteritis and tends to have a self-limited course. In contrast, chronic diarrhea presents a more complex diagnostic challenge due to its varied etiologies and clinical presentations. A shared feature among many causes of both acute and chronic diarrhea is an alteration in the gut microbiota, a condition referred to as dysbiosis. While acute infections often result in temporary microbial imbalance, chronic conditions such as irritable bowel syndrome and symptomatic uncomplicated diverticular disease are associated with persistent dysbiosis. This review aims to explore the most prevalent causes and underlying mechanisms of acute and chronic diarrhea, with a particular focus on the role of the gut microbiota. It will also examine the principal therapeutic strategies aimed at modulating intestinal microbiota, including prebiotics, probiotics, antibiotics, and fecal microbiota transplantation.

## Linked entities

- **Diseases:** irritable bowel syndrome (MONDO:0005052)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, NR1I2 (nuclear receptor subfamily 1 group I member 2) [NCBI Gene 8856] {aka BXR, ONR1, PAR, PAR1, PAR2, PARq}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, TRPV1 (transient receptor potential cation channel subfamily V member 1) [NCBI Gene 7442] {aka VR1}, VIP (vasoactive intestinal peptide) [NCBI Gene 7432] {aka PHM27}, CFTR (CF transmembrane conductance regulator) [NCBI Gene 1080] {aka ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR}
- **Diseases:** death (MESH:D003643), malnutrition (MESH:D044342), Acute and chronic diarrhea (MESH:D001930), Malabsorption (MESH:D008286), DGBI (MESH:D001927), water retention (MESH:D016055), lactose intolerance (MESH:D007787), colorectal cancer (MESH:D015179), exocrine pancreatic insufficiency (MESH:D010188), acute appendicitis (MESH:D001064), anemia (MESH:D000740), C. difficile (MESH:D003015), diarrheal (MESH:D004403), weight loss (MESH:D015431), ototoxicity (MESH:D006311), dehydration (MESH:D003681), metabolic acidosis (MESH:D000138), hepatobiliary or pancreatic diseases (MESH:D004066), chronic pancreatitis (MESH:D050500), Protozoa infections (MESH:D007239), diabetic neuropathy (MESH:D003929), hemolytic uremic syndrome (MESH:D006463), Crohn disease (MESH:D003424), C. difficile colitis (MESH:D003092), gastrointestinal disease (MESH:D005767), post-infectious IBS (MESH:D000094025), carcinoid tumors (MESH:D002276), hypokalemia (MESH:D007008), lactase deficiency (MESH:C562600), visceral hypersensitivity (MESH:D004342), constipation (MESH:D003248), hepatic encephalopathy (MESH:D006501), intestinal lymphoma (MESH:D008223), amyloidosis (MESH:D000686), IBS (MESH:D043183), enteric lymphoma (MESH:D004751), depression (MESH:D003866), ischemic colitis (MESH:D017091), IBD (MESH:D015212), abdominal bloating (MESH:D000007), organic disease (MESH:D000092124), ulcerative colitis (MESH:D003093), autonomic neuropathy (MESH:D009422), cognitive impairment (MESH:D003072), VIPoma (MESH:D003969), Secretory diarrhea (MESH:C564382), primary sclerosing cholangitis (MESH:D015209), SIBO (MESH:C538260), infectious (MESH:D003141), SUDD (MESH:D000076385), acute and chronic diarrhea conditions (MESH:D002908), pancreatic disease (MESH:D010182), dyspepsia (MESH:D004415), primary biliary cholangitis (MESH:D008105), bloating (MESH:C535647), immune dysregulation (OMIM:614878), hormone-secreting tumors (MESH:D049912), thyroid and parathyroid disorders (MESH:D010279), Giardiasis (MESH:D005873), reactive arthritis (MESH:D016918)
- **Chemicals:** rifaximin (MESH:D000078262), Na+ (MESH:D012964), caffeine (MESH:D002110), L. casei CNCM I-1572 (-), bile acid (MESH:D001647), propionate (MESH:D011422), butyrate (MESH:D002087), lipopolysaccharide (MESH:D008070), vitamin B12 (MESH:D014805), taurine (MESH:D013654), Prebiotics (MESH:D056692), glucose (MESH:D005947), vitamin B9 (MESH:D005492), neomycin (MESH:D009355), SCFAs (MESH:D005232), acetate (MESH:D000085), hydrogen (MESH:D006859), alcohol (MESH:D000438), fiber (MESH:D004043), mesalazine (MESH:D019804), FOS (MESH:C116580), lactose (MESH:D007785), norfloxacin (MESH:D009643), water (MESH:D014867), luminal (MESH:D010634), cAMP (MESH:D000242), chloride (MESH:D002712), rifamycin (MESH:C023808)
- **Species:** Lacticaseibacillus casei (species) [taxon 1582], Akkermansia muciniphila (species) [taxon 239935], Yersinia (genus) [taxon 444888], Cryptosporidium parvum (species) [taxon 5807], Norovirus (genus) [taxon 142786], Giardia duodenalis (species) [taxon 5741], Clostridium (genus) [taxon 1485], Faecalibacterium prausnitzii (species) [taxon 853], Homo sapiens (human, species) [taxon 9606], Clostridioides difficile (species) [taxon 1496], Bifidobacterium (genus) [taxon 1678], Vibrio cholerae (species) [taxon 666], Alistipes (genus) [taxon 239759], Shigella dysenteriae (species) [taxon 622], Bacteroides fragilis (species) [taxon 817], Adenoviridae (family) [taxon 10508], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Fusobacterium nucleatum (species) [taxon 851], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Enterobacteriaceae (enterobacteria, family) [taxon 543], Entamoeba histolytica (species) [taxon 5759], Enterococcus faecium (species) [taxon 1352], Rotavirus (genus) [taxon 10912], Escherichia coli (E. coli, species) [taxon 562], Bacillus cereus (species) [taxon 1396], Campylobacter (genus) [taxon 194], Salmonella (genus) [taxon 590], Cyanobacterium (genus) [taxon 102234], Mycobacterium avium complex sp. (species) [taxon 37162], Strongyloides stercoralis (species) [taxon 6248], Prevotella (genus) [taxon 838], Coprococcus (genus) [taxon 33042], Parabacteroides distasonis (species) [taxon 823], Collinsella aerofaciens (species) [taxon 74426], Ruminococcus (genus) [taxon 1263], Lactobacillus acidophilus (species) [taxon 1579], Citrobacter (genus) [taxon 544], Clostridia (class) [taxon 186801], Eggerthella lenta (species) [taxon 84112], Roseburia (genus) [taxon 841], Lacticaseibacillus paracasei (species) [taxon 1597]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12929882/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12929882/full.md

## References

160 references — full list in the complete paper: https://tomesphere.com/paper/PMC12929882/full.md

---
Source: https://tomesphere.com/paper/PMC12929882